Search results
Moderna First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 2 hours agoModerna (NASDAQ:MRNA) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91%...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 17 hours agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 1 day agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
Earnings call: Moderna reports a net loss of $12.2 billion By Investing.com
Investing.com· 15 hours agoModerna , Inc. (NASDAQ:MRNA) reported a mixed first quarter in 2024, with significant business...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 4 hours agoModerna experienced a substantial financial shift in the first quarter (Q1) of 2024, reporting a net loss of $1.2bn - a stark contrast to its net income...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 1 day agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 1 day agoModerna (MRNA) delivered earnings and revenue surprises of 14.48% and 33.88%, respectively, for the...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 20 hours agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via Yahoo News· 1 day ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 14 hours agoModerna (NASDAQ: MRNA) was a fine stock to heal an ailing portfolio on the second-to-last trading day of the week. The company, which developed and sells...
